Alpha1B adrenoceptor expression is a marker of reduced survival and increased tumor recurrence in patients with endometrioid ovarian cancer

Figure 3 Four adrenoceptor groups were modelled for (A) ovarian cancer specific survival (P = 0. 284) and (B) tumor recurrence (P = 0.061) according to the relative expression of α1B and α2C. Group 1: α1B^positive/αα2C^positive; Group 2: α1B^positive/α2C^negative; Group 3: α1B^negative/α2C^positive; Group 4: α1B^negative/α2C^negative. Patients showing α1B expression (Groups 1 and 2) showed worse survival compared to patients that had α2C positive tumors without α1B expression.